Capsugel Completes New Spray-Dried Dispersion Mfg. Facility

Capsugel has completed construction of a new pharmaceutical spray-dried dispersion (SDD) commercial manufacturing facility at its site in Bend, OR. The company invested $25 million to expand its commercial SDD capability at the site.
 
“This investment reflects Capsugel’s strategy to leverage our science- and engineering-based expertise to enable innovative dosage forms that improve the lives of patients and consumers,” said Amit Patel, president, Capsugel Dosage Form Solutions. “Capsugel continues to expand our capacity and capabilities to support a growing pipeline of customer projects from early-stage development all the way through late-stage clinical and commercial manufacture.”
 
Since acquiring Bend Research, Capsugel has added two commercial-scale spray dryers, bringing the total number of units at its Bend campus to three. According to the company, the new units use innovative dryer design and manufacturing plant technology to offer a significantly improved product throughput that minimizes cycle times and maximizes productivity. The newest unit, designed to accommodate high-potency compounds, will become fully operational later this year.